2,211 results match your criteria: "Beijing Youan Hospital[Affiliation]"
JAMA
November 2024
Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China.
Importance: The effect of high-intensity noninvasive positive pressure ventilation (NPPV) on the need for endotracheal intubation in patients with an acute exacerbation of chronic obstructive pulmonary disease (COPD) is unknown.
Objective: To determine whether the use of high-intensity NPPV vs low-intensity NPPV reduces the need for endotracheal intubation in patients with an acute exacerbation of COPD and hypercapnia.
Design, Setting, And Participants: Randomized clinical trial conducted at 30 general respiratory non-intensive care unit wards of Chinese hospitals from January 3, 2019, to January 31, 2022; the last 90-day follow-up was on April 22, 2022.
J Hepatocell Carcinoma
September 2024
Cancer Center, Beijing Tongren Hospital, Capital Medical University, Beijing, People's Republic of China.
Purpose: To determine the effect of aspirin on hepatocellular carcinoma (HCC) recurrence and survival after thermal ablation.
Methods: A retrospective analysis was performed to evaluate the efficacy and safety of aspirin in combination with thermal ablation. The clinical data were collected for the enrolled patients.
J Multidiscip Healthc
September 2024
Department of Nursing, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, People's Republic of China.
Purpose: To investigate and analyse the status quo of the self-management of patients living with HIV/AIDS (PLWHA) and its influencing factors and to provide the basis for formulating intervention strategies.
Methods: In this cross-sectional study, 300 PLWHA who visited the Infection Center of Beijing Youan Hospital, Capital Medical University between September 2021 and December 2021 were enrolled using the convenience sampling method. Demographic characteristics and disease-related data were collected for each participant.
Infect Agent Cancer
September 2024
Department of Pathology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Eur Radiol
September 2024
Beijing Chaoyang Hospital, Beijing, China.
Objectives: The Baveno VII consensus recommends endoscopic screening for varicose veins in cases of liver stiffness measurement (LSM) ≥ 20 kPa or platelet count ≤ 150 × 10/L. Whether this approach was appropriate for patients with primary biliary cholangitis (PBC) remains uncertain. This study expanded the observed risk factors by adding analysis of ultrasound images as a non-invasive tool to predict the risk of esophageal or fundic varices.
View Article and Find Full Text PDFAntivir Ther
October 2024
First Department of Liver Disease, Beijing YouAn Hospital, Capital Medical University, Beijing, China.
Background/aim: Tenofovir amibufenamide (TMF) employs innovative ProTide technology and a methylation strategy to enhance the lipid solubility and plasma stability of the amide bond, providing advantages over tenofovir alafenamide (TAF). Despite promising Phase III clinical trial results demonstrating its antiviral efficacy, real-world data on TMF remains scarce. This study evaluates the antiviral efficacy and safety of TMF compared to TAF as the initial treatment in patients with high viral loads of chronic hepatitis B (CHB).
View Article and Find Full Text PDFFront Pharmacol
August 2024
Department of Pharmacy, Beijing YouAn Hospital of Capital Medical University, Beijing, China.
Background And Objective: The main challenge for immunosuppressive therapy using tacrolimus in liver transplantation is the considerable variability in its oral bioavailability and the narrow treatment range. Many population pharmacokinetic (PopPK) models have been established to precisely estimate the PK variability of tacrolimus in liver transplant recipients. However, it remains unclear whether there is a significant difference in the PK behavior of tacrolimus between patients with or without liver cancer before surgery.
View Article and Find Full Text PDFFood Funct
September 2024
Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health) & School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.
Non-alcoholic fatty liver disease (NAFLD) poses a significant health threat due to its potential progression to liver fibrosis, cirrhosis, and even liver cancer. Without proper management, NAFLD can lead to severe complications and significantly impact overall health and longevity. This study explores the potential anti-steatosis effects of Nankun Mountain Mao tea (MT) on hepatic lipid accumulation using both and models.
View Article and Find Full Text PDFSci China Life Sci
January 2025
Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.
Clin Chim Acta
January 2025
West China Hospital, Sichuan University, Chengdu, China. Electronic address:
Background: Evaluating the clinical performance of Elecsys HIV Duo assay for primary human immunodeficiency virus (HIV) screening and acute HIV infection detection.
Methods: This study was conducted from April 2022 to April 2023 and involved two distinct populations. For the HIV screening population, three HIV Duo results [HIV Duo, HIV antigen (Ag), and HIV antibody (Ab)] in primary screening were obtained (January 2021 to June 2021).
Front Microbiol
August 2024
Department of Gastroenterology and Hepatology, Laboratory for Clinical Medicine, Beijing You'an Hospital Affiliated to Capital Medical University, Beijing, China.
Background: Numerous studies have confirmed that gut microbiota plays a crucial role in the progression of cirrhosis. However, the contribution of gut fungi in cirrhosis is often overlooked due to the relatively low abundance.
Methods: We employed 16S ribosomal RNA sequencing, internal transcribed spacer sequencing, and untargeted metabolomics techniques to investigate the composition and interaction of gut bacteria, fungi, and metabolites in cirrhotic patients.
Front Cell Infect Microbiol
September 2024
Beijing Youan Hospital, Capital Medical University, Beijing, China.
Background: Hepatic encephalopathy (HE) is a neurological disorder resulting from advanced liver injury. HE has a high mortality rate and poor prognosis. The pathogenesis of HE is still unclear, which has led to the lack of a satisfactory specific treatment method.
View Article and Find Full Text PDFFront Cell Infect Microbiol
August 2024
Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Background: Cryptococcosis is an invasive infection that commonly affects immunosuppressed individuals, especially patients with HIV infection. Cryptococcal infection in HIV-infected patients should be considered a major health concern because it is associated with high morbidity and mortality rates. In this study, we aimed to evaluate the clinical characteristics and prognostic factors of cryptococcal infections in human immunodeficiency virus (HIV)-infected patients to facilitate effective clinical management and improve patient outcomes.
View Article and Find Full Text PDFGut Liver
November 2024
Fourth Department of Liver Disease, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Ascites is the most common complication in patients with decompensated cirrhosis. This condition results in a severely impaired quality of life, excessive healthcare use, recurrent hospitalizations and significant morbidity and mortality. While loop diuretics and mineralocorticoid receptor antagonists are commonly employed for symptom relief, our understanding of their impact on survival remains limited.
View Article and Find Full Text PDFAnn Hematol
December 2024
Department of Respiratory and Critical Care Medicine, Beijing Youan Hospital, Capital Medical University, Beijing100069, China.
In people living with HIV (PLWH), the susceptibility to malignancies is notably augmented, with lymphoma emerging as a predominant malignancy. Even in the antiretroviral therapy (ART) era, aggressive B-cell lymphoma stands out as a paramount concern. Yet, the pathogenesis of HIV related lymphoma (HRL) largely remains an enigma.
View Article and Find Full Text PDFJ Infect Dis
December 2024
Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC), Beijing Academy of Preventive Medicine, Beijing.
J Infect Dis
November 2024
Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Control and Prevention (CDC), Beijing Academy of Preventive Medicine, Beijing.
Virol Sin
October 2024
Department of Health Sciences, National Natural Science Foundation of China, Beijing, 100085, China; Beijing Key Laboratory for HIV/AIDS Research, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China; Central Laboratory, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China. Electronic address:
Clin Gastroenterol Hepatol
February 2025
Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China; State Key Laboratory of Organ Failure Research, Guangzhou, China; Key Laboratory of Infectious Diseases Research in South China, Ministry of Education, Guangzhou, China; Guangdong Provincial Key Laboratory for Prevention and Control of Major Liver Diseases, Guangzhou, China; Guangdong Provincial Clinical Research Center for Viral Hepatitis, Guangzhou, China. Electronic address:
Jpn J Clin Oncol
December 2024
Department of Pharmacy, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
Background: Hepatitis B virus (HBV) reactivation is a recognized complication of cytotoxic chemotherapy in patients with chronic hepatitis B. However, the risk of HBV reactivation with immune checkpoint inhibitors (ICIs) remains uncertain due to their exclusion from clinical trials. This study aimed to assess the incidence of HBV reactivation in patients with cancer undergoing ICI therapy, exploring associated risk factors.
View Article and Find Full Text PDFHepatobiliary Surg Nutr
August 2024
Department of Liver Surgery, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College (PUMC) & Chinese Academy of Medical Sciences (CAMS), Beijing, China.
Gastroenterol Rep (Oxf)
August 2024
The Third Unit, Department of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, P. R. China.
Med Oncol
August 2024
Beijing Institute of Hepatology, Beijing YouAn Hospital, Capital Medical University, Beijing, People's Republic of China.
Breast cancer, as a highly prevalent cancer among women, is one of the main causes of female mortality due to cancer. There is a need for more treatment options to improve the survival time of breast cancer patients. Metastasis to distant organs is a standard indicator of advanced breast cancer and a primary cause of breast cancer mortality, making the control of breast cancer metastasis crucial.
View Article and Find Full Text PDFWorld J Gastrointest Oncol
August 2024
Department of Pathology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
Background: Hepatocellular carcinoma (HCC) is a major cause of cancer mortality worldwide, and metastasis is the main cause of early recurrence and poor prognosis. However, the mechanism of metastasis remains poorly understood.
Aim: To determine the possible mechanism affecting HCC metastasis and provide a possible theoretical basis for HCC treatment.
J Pharm Biomed Anal
December 2024
Department of Emergency, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100007, China. Electronic address:
Sepsis is a life-threatening condition and usually be treated with antibiotics, which however often has severe side effects. This work proposed a novel Chinese traditional medicine JINHONG (JH) decoction for therapy of sepsis. We first identified the chemical constituents of JH decoction by using high-performance liquid chromatography and mass spectrometry (HPLC-MS).
View Article and Find Full Text PDF